1.
2.
Article
in English
| IMSEAR
| ID: sea-64955
ABSTRACT
Intravesical bacillus Calmette-Guerin (BCG) is used in patients with urinary bladder carcinoma. Although it is generally well tolerated, granulomatous hepatitis is a rare but serious complication. We report a 42-year-old man and a 56-year-old man who developed granulomatous hepatitis following intravesical BCG. One of them was treated successfully with antitubercular therapy; the other died because of BCG sepsis and multi-organ failure.
Subject(s)
Administration, Intravesical , Adult , Antitubercular Agents/therapeutic use , BCG Vaccine/adverse effects , Biopsy, Needle , Carcinoma, Transitional Cell/drug therapy , Fatal Outcome , Humans , Liver/microbiology , Male , Middle Aged , Tuberculosis, Hepatic/drug therapy , Urinary Bladder Neoplasms/drug therapy
3.
Article
in English
| IMSEAR
| ID: sea-65171